search
  • Country
    Clear
  • Type
  • Compatibility Level
  • Thematic
  • Jurisdiction
2,881 Data sources

  • NL
  • FR
  • SG
  • KR

  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • This site provides access to the output of the institution. Users may set up an RSS feed to be alerted to new content. Some items are not available as full-text. The interface is available in French and English. Additional services such as exporting of publications lists are available. Some items are linked to their PubMed records

    more_vert
  • more_vert
  • Online storage, sharing and registration of research data, during the research period and after its completion. DataverseNL is a shared service provided by participating institutions and DANS.

    more_vert
  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • chevron_left
  • 4
  • 5
  • 6
  • 7
  • 8
  • chevron_right
2,881 Data sources
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • This site provides access to the output of the institution. Users may set up an RSS feed to be alerted to new content. Some items are not available as full-text. The interface is available in French and English. Additional services such as exporting of publications lists are available. Some items are linked to their PubMed records

    more_vert
  • more_vert
  • Online storage, sharing and registration of research data, during the research period and after its completion. DataverseNL is a shared service provided by participating institutions and DANS.

    more_vert
  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • chevron_left
  • 4
  • 5
  • 6
  • 7
  • 8
  • chevron_right